Replies to post #182680 on NorthWest Biotherapeutics Inc (NWBO)

[kabunushi]

I agree that a partnership worth 8 figures would be a slam dunk confirmation of value and near certainty of approval. In the meantime, even a cash out refi for 8 figures would hardly be a negative. It would not imply that a partnership geographic licensing is off the table and would help by putting a floor under the stock and reverse direction of the pps. Especially if backed up by new data including at least the most recent count of surviving patients. I expect to hear that at a minimum this month or next. I know it's hard to continue to be patient but it would be sick to throw away a winning hand before 1-2 aces are dealt face up. JMO.

[Umibe5690]

It is highly unlikely that funding through a partnership at this stage will take place. A partner would want to get in on the cheap if it advanced funding to NWBO. Why would NWBO do any better by going into partnership with big P in raising funds as opposed to doing a toxic equity offering? Funding from a bad partnership deal is likely not gonna happen. Just like a cheap BO ain't gonna happen.

If NWBO is gonna get better financing than bleeding toxic funding by a thousand cuts, it will do a loan deal. If Sawston is not yet fully collateralized, then there will be a refi. Values have increased dramatically on the property, so a good bet is a refi. LP has to avoid toxic financing now more than ever owing to the botched pub/ASCO presentation that was supposed to raise the pps. She is under a lot of pressure and has very limited financing options. Sawston is most likely. JMHO.